Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

UCLA's Jonsson Comprehensive Cancer Center

10945 Le Conte Ave.     
Los Angeles , CA 90095
USA

 

Principal Investigator:
Bartosz Chmielowski
Contact:
310-206-3669 bchmielowski@mednet.ucla.edu Jackie Hernandez 310-794-6913
Activation Status of this Site:
Closed
Notes about this Site:
UCLA's Jonsson Comprehensive Cancer Center Website:
http://www.cancer.ucla.edu/Index.aspx?page=51

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.